{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:28:42Z","timestamp":1778758122477,"version":"3.51.4"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T00:00:00Z","timestamp":1525910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSN272200800028C"],"award-info":[{"award-number":["HHSN272200800028C"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0197011","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T13:32:56Z","timestamp":1525959176000},"page":"e0197011","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["An ambient temperature-stable antitoxin of nine co-formulated antibodies for botulism caused by serotypes A, B and E"],"prefix":"10.1371","volume":"13","author":[{"given":"Mingxiang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chidi R.","family":"Obi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel K.","family":"Freeberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4130-6332","authenticated-orcid":true,"given":"Shauna","family":"Farr-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan T.","family":"Tomic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,10]]},"reference":[{"key":"ref1","unstructured":"(2012) Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Implementation Plan Available online: http:\/\/www.phe.gov\/Preparedness\/mcm\/phemce\/Documents\/2012-PHEMCE-Implementation-Plan.pdf<\/ext-link>."},{"key":"ref2","unstructured":"(2004) Summary of the NIAID expert panel on botulinum neurotoxintherapeutics. Available at: https:\/\/www.niaid.nih.gov\/sites\/default\/files\/report_bont.pdf<\/ext-link>."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/infdis\/jit449","article-title":"A Novel Strain of Clostridium botulinum<\/italic> That Produces Type B and Type H Botulinum Toxins","volume":"209","author":"JR Barash","year":"2014","journal-title":"J Infect Dis"},{"key":"ref4","article-title":"Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H","volume":"9","author":"G Yao","year":"2017","journal-title":"Toxins (Basel)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JB.01180-06","article-title":"Genetic diversity among Botulinum Neurotoxin-producing clostridial strains","volume":"189","author":"KK Hill","year":"2007","journal-title":"J Bacteriol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","article-title":"Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization","volume":"73","author":"TJ Smith","year":"2005","journal-title":"Infect Immun"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nbt1269","article-title":"Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin","volume":"25","author":"C Garcia-Rodriguez","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e5355","DOI":"10.1371\/journal.pone.0005355","article-title":"Extraction and inhibition of enzymatic activity of botulinum neurotoxins\/A1, \/A2, and \/A3 by a panel of monoclonal anti-BoNT\/A antibodies","volume":"4","author":"SR Kalb","year":"2009","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijms.2008.04.004","article-title":"The use of endopep-MS to detect multiple subtypes of BoNT\/A, B, E, and F","volume":"278","author":"SR Kalb","year":"2008","journal-title":"Int J Mass Spec"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"SA Arnon","year":"2001","journal-title":"JAMA"},{"key":"ref11","unstructured":"(1998) Botulism in the United States, 1899\u20131998. Handbook for epidemiologists, clinicians, and laboratory workers. Available online: https:\/\/www.cdc.gov\/botulism\/pdf\/bot-manual.pdf<\/ext-link> Atlanta, Georgia: US Department of Health and Human Service, Public Health Service, Centers for Disease Control and Prevention."},{"key":"ref12","author":"JK Rao AK","year":"2013"},{"key":"ref13","unstructured":"(2013) Cangene Corp., BAT\u00ae [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)\u2014(Equine)] Sterile Solution for Injection. Available online: https:\/\/www.fda.gov\/downloads\/\u2026\/UCM345147.pdf<\/ext-link>"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"A Nowakowski","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"E105","DOI":"10.3390\/toxins10030105","article-title":"A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes","volume":"10","author":"C Garcia-Rodriguez","year":"2018","journal-title":"Toxins (Basel)"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3390\/toxins9100309","article-title":"The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies","volume":"9","author":"C Rasetti-Escargueil","year":"2017","journal-title":"Toxins"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3390\/toxins8090257","article-title":"Neutralization of botulinum neurotoxin type E by a humanized antibody","volume":"8","author":"Y Derman","year":"2016","journal-title":"Toxins"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"A Nowakowski","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/IAI.69.1.570-574.2001","article-title":"High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A","volume":"69","author":"DD Pless","year":"2001","journal-title":"Inf Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/protein\/gzq111","article-title":"Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin","volume":"24","author":"C Garcia-Rodriguez","year":"2011","journal-title":"Protein Eng Des Sel"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1021\/ac401455f","article-title":"Nondenaturing size-exclusion chromatography-mass spectrometry to measure stress-induced aggregation in a complex mixture of monoclonal antibodies","volume":"85","author":"J Woodard","year":"2013","journal-title":"Analytical chemistry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e0006133","DOI":"10.1371\/journal.pntd.0006133","article-title":"SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies","volume":"11","author":"TY Chao","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"324ra314","DOI":"10.1126\/scitranslmed.aad5640","article-title":"MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations","volume":"8","author":"S Arena","year":"2016","journal-title":"Sci Transl Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/bph.13450","article-title":"Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18","volume":"173","author":"S Carvalho","year":"2016","journal-title":"Br J Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jmb.2005.06.003","article-title":"Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A","volume":"351","author":"A Razai","year":"2005","journal-title":"J Mol Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/protein\/gzq001","article-title":"Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating","volume":"23","author":"J Lou","year":"2010","journal-title":"Protein Eng Des Sel"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1128\/AAC.02830-14","article-title":"Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A","volume":"58","author":"SU Nayak","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","unstructured":"Babuka SH, CY; Li, M, (2011), US20110059079 A1, Antibody coformulations"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jim.2013.02.010","article-title":"Discovery of diverse and functional antibodies from large human repertoire antibody libraries","volume":"391","author":"LJ Schwimmer","year":"2013","journal-title":"J Immunol Methods"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ab.2012.08.005","article-title":"Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein","volume":"430","author":"Q Meng","year":"2012","journal-title":"Anal Biochem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ab.2011.09.030","article-title":"Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein","volume":"421","author":"Q Meng","year":"2012","journal-title":"Anal Biochem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.chroma.2010.10.107","article-title":"Separation of oxidized variants of a monoclonal antibody by anion-exchange","volume":"1218","author":"G Teshima","year":"2011","journal-title":"J Chromatogr A"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0197011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:52:23Z","timestamp":1540032743000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0197011"}},"subtitle":[],"editor":[{"given":"Ellen R.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,10]]},"references-count":32,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0197011","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,10]]}}}